期刊文献+
共找到1篇文章
< 1 >
每页显示 20 50 100
Non-alcoholic fatty liver disease:Is surgery the best current option and can novel endoscopy play a role in the future?
1
作者 Mandour Omer Mandour mohammed el-hassan +1 位作者 Rawan M Elkomi Jude A Oben 《World Journal of Hepatology》 2022年第9期1704-1717,共14页
alcohol as the leading cause of cirrhosis in the Western world.There remains to be a licensed pharmacological treatment for NAFLD.Weight loss is advised for all patients with NAFLD.Many patients however,struggle to lo... alcohol as the leading cause of cirrhosis in the Western world.There remains to be a licensed pharmacological treatment for NAFLD.Weight loss is advised for all patients with NAFLD.Many patients however,struggle to lose the recommended weight with lifestyle modification alone.Many drugs have either failed to show significant improvement of steatosis or are poorly tolerated.Bariatric surgery has been shown to reduce liver steatosis and regress liver fibrosis.The pathophysiology is not fully understood,however recent evidence has pointed towards changes in the gut microbiome following surgery.Novel endoscopic treatment options provide a minimally invasive alternative for weight loss.Randomised controlled trials are now required for further clarification. 展开更多
关键词 Obesity Metabolic associated fatty liver disease Non-alcoholic fatty liver disease Non-alcoholic steatohepatitis Bariatric endoscopy Bariatric surgery©The Author(s)2022.Published by Baishideng Publishing Group Inc.All rights reserved
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部